SCHEMBL17599375

SCHEMBL17599375

Cc1c(S(=O)(=O)Nc2ccc(-c3cc(C(=O)O)ccc3F)c3ncccc23)c2ccccc2n1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 1/20 0.49
▸ KDM4E B2RXH2 3/20 0.43
▸ SLC40A1 Q9NP59 4/20 0.41
▸ MMP2 P08253 3/20 0.41
▸ GLO1 Q04760 2/20 0.40
▸ MMP9 P14780 1/20 0.39
▸ KEAP1 Q14145 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ FABP4 P15090 1/20 0.38
▸ PTK2B Q14289 1/20 0.38
▸ CKS1B P61024 2/20 0.38
▸ SKP2 Q13309 2/20 0.38
▸ SLC16A3 O15427 1/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599357 0.81 KDM4E (0.46) KDM4ESLC40A1MMP2GLO1MMP9
SCHEMBL17599395 0.80 KDM4E (0.37) KDM4ESLC40A1MMP2GLO1MMP9
SCHEMBL17613389 0.79 ACLY (0.47) ACLYKDM4ESMN1; SMN2NPC1ALDH1A1
SCHEMBL17599385 0.77 TSHR (0.47) ACLYSMN1; SMN2FABP4PTK2BSLC16A3
SCHEMBL17599334 0.75 PFKFB4 (0.41) KDM4ESLC40A1MMP2GLO1MMP9
SCHEMBL17599377 0.75 PFKFB3 (0.56) KEAP1
SCHEMBL17599320 0.74 SMN1; SMN2 (0.54) ACLYKDM4ESMN1; SMN2TDP1HTT
SCHEMBL17599370 0.73 ALDH1A1 (0.53) ACLYKDM4EKEAP1SMN1; SMN2ALDH1A1
SCHEMBL17599305 0.73 ACLY (0.55) ACLYSMN1; SMN2FABP4PTK2BSLC16A3
SCHEMBL17599448 0.71 KEAP1 (0.73) ACLYKDM4ESLC40A1MMP2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP claimed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback